Viraj Tyagi
Global Alliance Leader, Strategic Partnering, Precision Medicine & Diagnostics Johnson & Johnson Innovative Medicine
Viraj Tyagi is a Global Alliance Leader of Oncology Precision Medicine & Diagnostics at Johnson & Johnson, where he leads the partnering team that drive collaborations, governance, and tools to advance J&Js extensive oncology portfolio. Prior to joining J&J in 2024, Viraj held leadership roles at Alnylam (Senior Director – Business Strategy & Operations) where he led several critical organizational capability-building initiatives, at Takeda (Director of Partnerships) where he helped establish the partnership office and write the partnering playbook while leading Cell & Gene Therapy Alliances, and Novartis where he spent almost a decade in a variety of roles spanning Business development and Portfolio Management. The opportunity for strategic & mutual benefit between two organizations that leads to better and faster therapies for patients that are waiting is what drives him.
Seminars
- The next breakthrough in precision medicine may not come from a new biomarker or a new diagnostic technology. It may come from how effectively organizations coordinate them
- As companion diagnostics evolve into broader ecosystems spanning AI, liquid biopsy, MRD, digital pathology, and real-world evidence, traditional partnering approaches are being tested in new ways. As complexity increases, partnering must evolve
- This session explores how J&J is adapting to increasing complexity and what the future of collaboration may look like across pharma, biotech, and diagnostics
